Bury, United Kingdom

Andrew Lloyd

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bally Gaming, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Lloyd. Retrieved from https://idiyas.com/inventor/andrew-lloyd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Lloyd - Innovator in Drug Delivery Systems

Introduction

Andrew Lloyd is an inventor based in Sussex, GB. He is associated with Biocompatibles UK Limited, where he focuses on developing innovative drug delivery systems. Although he currently holds no granted patents, his work in the field of microparticles and drug delivery is noteworthy.

Latest Patent Applications

Andrew Lloyd's latest patent application is titled "Drug Delivery Systems." This invention relates to microparticles comprising a gel body, wherein the gel body consists of a synthetic polymer and a drug. The microparticles have an average diameter ranging from 40 to 1500 μm. The polymer is cross-linked by groups comprising disulfide linkages and is in the form of a hydrogel. This innovative approach aims to enhance the effectiveness of drug delivery methods.

Conclusion

Andrew Lloyd is making significant contributions to the field of drug delivery systems, showcasing his potential as an inventor. His work at Biocompatibles UK Limited highlights the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…